SOURCE: MMRGlobal, Inc.

MMRGlobal, Inc.

May 07, 2014 08:15 ET

MMRGlobal Names Health IT Insurance Executive Joseph Gonzalez and Leading Australian Physician and eHealth Innovator Dr. Joseph Grace to Advisory Boards

LOS ANGELES, CA--(Marketwired - May 7, 2014) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"), a leading provider of patented Personal Health Records (PHRs), MyEsafeDepositBox storage solutions, and MMRPro document management and imaging systems for healthcare professionals, today announced the appointments of Joseph Gonzalez to the MMR Board of Advisors and Dr. Joseph Gracé to the Company's Medical Board of Advisors. Mr. Gonzalez co-founded Secure EDI Health Group and has served as the primary consultant for initiatives with the nation's leading companies in the financial, healthcare, and clinical data verticals for over 15 years. He will assist the Company in forming strategic relationships with major Health Information Technology solution providers. Dr. Gracé will assist MMR with the Company's ongoing licensing and sales initiatives in Australia in advance of scheduled meetings with MMR executives and strategic partners later this summer.

Mr. Gonzalez has held leadership roles with industry driving organizations and associations. He currently holds the position of President for The Cooperative Exchange,, the recognized resource and representative association of the Healthcare IT Vendor and Clearinghouse industry. Previously, he served as Vice Chairman and Trustee of the Board of Directors to the National Dental EDI Council, and has chaired or co-chaired committees and workgroups within ASC X12, Workgroup for Electronic Data Interchange (WEDI), Center for Affordable Quality Healthcare's (CAQH) CORE initiative and the Electronic Healthcare Network Accreditation Commission (EHNAC). He has also been a featured speaker on 4010/5010 transaction transition, Innovations in Electronic Remittance, ICD-10 preparedness, and authored white papers on Clinical Data & Electronic Medical Record strategies and solutions.

Dr. Gracé is a respected medical practitioner in Sydney, Australia for more than 26 years. He is currently the Medical Director of the North Shore Medical Group, offering specialist medical services to patients from over 800 referring doctors. Clinics under his purview include North Shore Heart Clinic®, North Shore Vein Clinic® and North Shore Homecare Services.

Dr. Gracé's extensive medical experience has accorded him Fellowships with the Australasian College of Phlebology, the Royal Australasian College of General Practitioners, and the Australian College of Nutritional and Environmental Medicine. In parallel with his clinical practice, he founded the startup health IT company, Claydata, collaborating with major research institutes to create better e-health and EMR solutions. Amongst other achievements, Dr. Gracé has taken Claydata's innovative eHealth technologies to the NSW Trade & Investment's INNOVATE NSW Collaborative Solutions conference and developed a consortium partnership with the University of New South Wales' Asia-Pacific Ubiquitous Health Care Research Centre. Dr. Gracé will assist MMR in introducing both the MMR platform of patented Personal Health Record products and services and related intellectual property along with strategic partner 4medica's integrated EHR (iEHR®) platform to physicians, providers, information providers and government agencies in Australia.

Robert H. Lorsch, MMRGlobal Chairman and Chief Executive Officer, said, "I am pleased to announce the addition of these two exceptional individuals to our advisory boards. Mr. Gonzalez's knowledge in health IT payer/provider solutions and services will be extremely valuable to MMR, while Dr. Gracé is both a gifted clinician and innovator in health IT. He is actively developing eHealth solutions in Australia and will be invaluable in demonstrating physician support to the use of Personal Health Records. He is also working with us on expanding MMR's licensing opportunities in Australia. He is as committed, as is MMR globally, to a mission of helping Australians benefit from effective eHealth technologies."

Members of the Company's Board of Advisors also include Dr. Buzz Aldrin, Apollo 11 Astronaut and author; Titus Day, Managing Director, 6 Degrees Group; Hon. Richard A. Gephardt, 22nd Majority Leader of the U.S. House of Representatives and currently President and CEO, Gephardt Government Affairs; C. Rowland Hanson, Strategic Marketing Consultant, former executive with Microsoft and Neutrogena; Hon. Asa Hutchinson, former U.S. Congressman, First Under Secretary of Homeland Security and currently CEO and Founding Partner, Hutchinson Group, LLC; "Sugar" Ray Leonard, Professional Athlete and Entrepreneur; Fred Middleton, Managing Director, Sanderling Ventures; Dr. James L. Spigarelli, former CEO and President, Midwest Research Institute; and JJ Virgin, CNS, CHFI, Health Correspondent, Author and Nutritionist.

The Company's Medical Advisory Board also includes Michel Babajanian, M.D., FAC., Board-Certified Otolaryngologist and Head and Neck Surgeon; Glenn D. Braunstein, M.D., Vice President, Clinical Innovation and Director of the Thyroid Cancer Center at Cedars-Sinai Medical Center; David E. Bresler, PhD, LAc, Author, Consultant and President, Academy for Guided Imagery; Shekhar Challa, M.D., Board-Certified Gastroenterologist and Co-Founder and President, Kansas Medical Clinic; Jeremy Fine, M.D., Board-Certified in Internal Medicine; Theodore B. Goldstein, M.D., Board-Certified Orthopedic Surgeon and Co-Medical Director, Cedars-Sinai Spine Center; William H. Goodman, M.D., Pulmonary and Critical Care Physician, Academic Appointment at Dartmouth Medical School; Cara Natterson, M.D., Board-Certified Pediatrician, Author and Founder, Worry Proof Consulting; Lawrence D. Piro, M.D., Clinician, International Expert in Hematologic Malignancies, The Angeles Clinic and Research Institute; David Charles Rish, M.D., Board-Certified Dermatologist; and Prediman K. (PK) Shah, M.D., Shapell and Webb Chair in Clinical Cardiology, Professor of Medicine and Cardiology, and Director, Oppenheimer Atherosclerosis Research Center at Cedars-Sinai Medical Center.

About MMRGlobal
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit View demos and video tutorials of the Company's products and services at

Forward-Looking Statements
 All statements in this press release that are not strictly historical in nature, including, without limitation, the Company's future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "potential," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Actual outcomes and results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, agents, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, monetize and protect our patent portfolio for both the Company's health IT and biotechnology intellectual property assets in the U.S. and internationally; the timing of milestone payments in connection with licensing our intellectual property; our ability to establish and maintain strategic relationships; changes in our relationships with our licensees; the risk the Company's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; the timing and volume of sales and installations; the length of sales cycles and the installation process; the market's acceptance of new product and service introductions; programs and initiatives, including the MMR Stimulus Program; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry both in the U.S. and internationally; undetected errors in our products; the possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. The Company is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.

Contact Information